Searched for
MERCK SERONO
US President Donald Trump to announce new deals to lower drug prices, White House saysPresident Trump is set to announce new agreements Friday aimed at lowering prescription drug prices, with major drugmakers like AbbVie, Bri...- Merck KGaA bets on cancer drugs to revitalise German firmMerck KGaA is betting on its oncology pipeline to revitalise the German drugmaker as it sees falling sales from its best-selling medicine, ...
- Dr Reddy's Laboratories, BioMarin settle patent litigation on Kuvan tabletsBioMarin has entered into a settlement agreement with Dr Reddy's Laboratories to resolve patent litigation in the US regarding Kuvan.
- German drug maker Merck KGaA finds Indian market promising for its pharma, consumer health businessMerck KGaA, the family-controlled $12.5-billion German drug maker, has identified India as one of its key markets under aglobal expansion s...
- CNX Pharma at record high; Sun Pharma, Ranbaxy on rollAmong the top performers in the pharma space have been Sun Pharmaceuticals, Ranbaxy, Lupin and Aurobindo Pharmaceuticals.
- Why Lupin isn't reacting to alliance with Merck SeronoWhen the company announced long-term strategic partnership with Merck Serono (MS), the biopharmaceutical division of Merck, the stock came ...
- Lupin inks pact with Merck Serono to expand in emerging marketsSales in the emerging market regions are one of the key growth drivers for Darmstadt-based Merck Serono, amounting to close to 1.8 billion ...
- Lupin likely to sign $1.5 billion deal with Merck SeronoLupin will manufacture Merck Serono’s $1.5 billion worth branded mature drugs at its facilities. The company will also get marketing rights...
- Sun Pharmaceutical's Dilip Shanghvi tops global rich list of drugmakers with net worth of $17.2 billionShanghvi is currently in the midst of getting clearances for his company’s $4-billion acquisition of Ranbaxy Laboratories.
- MNC drug companies like Roche, Merck Serono, Novartis see top deck reshuffleThese companies not only had to battle slow growth but also the fickle stand of Indian government over issues of intellectual property and ...
- Merck Serono supports India’s two-tier drug pricing policyMerck Serono, has not only become the latest global giant to support lower pricing for emerging markets but has also opposed incremental in...
- Indian Biotech industry growing at 15% annually, abundant job opportunities'Many pharmaceutical companies have established R&D centers in India and are considering tapping India’s talent', says Lawrence Ganti.
- Dr Reddy's, Merck to jointly develop biosimilarsmanufacturing of the compounds and will lead phase-III development.
- Ranbaxy plans to launch growth hormone drugRanbaxy Laboratories is planning a new growth hormone product to target the emerging global market for new versions of patent-expired biote...
- Mylan buys Merck’s generics unitMylan Laboratories agreed to buy Merck KGaA’s generic-drug unit for 4.9 billion euros ($6.7 billion) in cash to become the world’s third-la...
- Aurigene tech enters collaboration with Forest LabsThe company has also entered into a discovery collaboration with biotechnology company Merck Serono International
- Merck buy may give Ranbaxy access to US, Europe marketsRanbaxy Labs has joined the race with global pharma companies such as Teva, Novartis and Sanofi-Aventis for acquiring the global generic dr...
- Ranbaxy may pop Merck pillRanbaxy Labs has entered the race for acquiring the global generic drug business of Merck KGaA.
- Merck to acquire biotech firm Serono for $13.3 bnGerman drugmaker Merck unveiled a surprise 16.6-bn-Swiss franc ($13.3 bn) deal to buy Swiss biotech firm Serono on Thursday, creating a new...
- Takeover talk lifts Ciba, ClariantShares in speciality chemicals firms Ciba and Clariant rose strongly on Thursday, boosted by fresh takeover talk following a $13.3 bn tie-u...
Load More
